Altogether, these data demonstrate that MGL deletion favors the accumulation of AA in the intestine, triggering protective mechanisms through NR activation counteracting cholestatic liver disease progression, as summarized in Fig. 8F. This evidence concerns the gene MGLL and Cholestatic liver disease.